EMA advises restricted use of MS drug alemtuzumab

Healthcare professionals should consider stopping treatment in patients who develop signs of certain conditions–new recommendations.
Healthcare professionals should consider stopping treatment in patients who develop signs of certain conditions–new recommendations.